首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   29597篇
  免费   2260篇
  国内免费   97篇
耳鼻咽喉   264篇
儿科学   1050篇
妇产科学   856篇
基础医学   4028篇
口腔科学   431篇
临床医学   3960篇
内科学   5514篇
皮肤病学   631篇
神经病学   2983篇
特种医学   689篇
外国民族医学   2篇
外科学   2754篇
综合类   261篇
一般理论   25篇
预防医学   3808篇
眼科学   597篇
药学   1662篇
  1篇
中国医学   28篇
肿瘤学   2410篇
  2024年   50篇
  2023年   383篇
  2022年   547篇
  2021年   1045篇
  2020年   741篇
  2019年   997篇
  2018年   1183篇
  2017年   874篇
  2016年   934篇
  2015年   1030篇
  2014年   1294篇
  2013年   1823篇
  2012年   2582篇
  2011年   2544篇
  2010年   1341篇
  2009年   1200篇
  2008年   1907篇
  2007年   1978篇
  2006年   1750篇
  2005年   1582篇
  2004年   1432篇
  2003年   1306篇
  2002年   1239篇
  2001年   176篇
  2000年   97篇
  1999年   134篇
  1998年   209篇
  1997年   176篇
  1996年   134篇
  1995年   112篇
  1994年   108篇
  1993年   92篇
  1992年   76篇
  1991年   66篇
  1990年   45篇
  1989年   53篇
  1988年   31篇
  1987年   35篇
  1986年   38篇
  1985年   34篇
  1984年   44篇
  1983年   34篇
  1982年   49篇
  1981年   34篇
  1980年   39篇
  1979年   20篇
  1978年   22篇
  1977年   23篇
  1976年   27篇
  1973年   15篇
排序方式: 共有10000条查询结果,搜索用时 11 毫秒
1.
2.
3.
OBJECTIVE: Respiratory muscle endurance of able-bodied persons, assessed by normocapnic hyperpnoea at 70% of their maximal voluntary ventilation, usually ranges from 10 to 20 minutes. The aim of this study was to determine the level of ventilation that patients with paraplegia and tetraplegia can sustain for 10-20 minutes to later be used as the guideline for respiratory muscle endurance training. DESIGN: Pilot study; cross-over setting. SUBJECTS: Two groups, 8 patients with paraplegia and 6 with tetraplegia. METHODS: Respiratory muscle endurance tests were performed at 3 different intensities of normocapnic hyperpnoea, i.e. 20%, 40% and 60% maximal voluntary ventilation. Subjects performed partial re-breathing from a bag to assure normocapnia. Respiratory endurance was separately analysed for patients with paraplegia and tetraplegia. RESULTS: Mean respiratory endurance times were 46.0, 18.9 and 4.2 minutes at 20%, 40% and 60% maximal voluntary ventilation in patients with tetraplegia and 51.8, 38.8 and 12.2 minutes in patients with paraplegia. The duration differed significantly at 60% maximal voluntary ventilation between the groups. CONCLUSION: Minute ventilation to perform respiratory muscle endurance training can be set at around 40% of maximal voluntary ventilation for patients with tetraplegia and around 60% of maximal voluntary ventilation for patients with paraplegia, as these levels can be sustained for 10-20 minutes.  相似文献   
4.
Campath-1H (alemtuzumab) induction was used for renal transplantation in combination with sirolimus as immunosuppression. We previously reported a high (28%) rate of early rejection with this regimen, and now report 3-year outcomes. Twenty-nine patients were recipients of either deceased donor or non-HLA (Human Leukocyte Antigen) identical living donor primary renal allografts. Clinical parameters including infection, malignancy, kidney function, and kidney histology were followed prospectively for 3 years. Three-year cumulative graft and patient survival were 96% and 100%, respectively. Twenty patients were maintained on steroid-free immunosuppressive regimens, and 15 patients were maintained on monotherapy for immunosuppression (12 on sirolimus). No serious infectious complications were observed and two patients developed basal cell skin cancer. The 3-year results of our initial pilot study demonstrate good graft (96%) and patient (100%) outcomes. Campath-1H induction has yielded a high proportion of patients maintained on immunosuppressive monotherapy (57%) without serious infectious- and no malignancy-related complications. The reported regimen yielded novel insights into both Campath-1H and sirolimus therapy in renal transplantation. Because of the higher incidence of early rejection, we recommend a modified strategy of immunosuppression including a brief course of a calcineurin inhibitor.  相似文献   
5.
Abstract: Background: Identification of risk drinking in expectant fathers may be helpful as an important part of efforts to minimize maternal alcohol use, and as an opportunity to inform them about a problematic practice during a critical developmental stage for the couple. The purpose of this study was to evaluate the T‐ACE screening questionnaire, which asks about t olerance to alcohol, being a nnoyed by other's comments about drinking, attempts to c ut down, and having a drink first thing in the morning (“ e ye‐opener”), in the male partners of pregnant women who themselves were T‐ACE positive. Methods: Two hundred fifty‐four male partners were asked to complete the T‐ACE embedded in a health survey, the Alcohol Use Disorders Identification Test (AUDIT), and other questions about their alcohol use in the past 30 days when their pregnant partners had a median gestation of 11.5 weeks (T1). After delivery, male partners again completed the T‐ACE and quantity‐frequency questions (T2). The predictive ability of the T‐ACE and AUDIT was compared, using risk drinking (>4 drinks/day or >14 drinks/week) as the criterion standard. Results: A substantial minority of male partners had risk drinking, 31 percent at T1 and 25 percent at T2. Although the AUDIT was better than the T‐ACE as an independent predictor of risk drinking, the latter was most accurate when the tolerance threshold exceeded 2 drinks, the same established for pregnant women. The sensitivity (T1 = 84.6%, T2 = 82.8%) and specificity (T1 = 43.8%, T2 = 51.1%) of the T‐ACE at this threshold compared favorably with those of the AUDIT at the standard cut point of 8. Conclusions: The T‐ACE may be a practical way for clinicians to identify risk drinking in both pregnant women and expectant fathers. (BIRTH 33:2 June 2006)  相似文献   
6.
7.
Many polycyclic aromatic hydrocarbons containing peripherallyfused cyclopenta rings are believed to be activated primarilyby epoxidation of the cyclopenta ring. The cyclopenta epoxidesof a series of four cyclopenta benzanthracene derivatives, benz[e]aceanthrylene-5,6-oxide,benz[j]ace-anthrylene-1,2-oxide, benz(l)anthrylene-1,2-oxideand benz[k]acephenaceanthrylene-4,5-oxide were synthesized fromtheir parent hydrocarbons by formation of the bromohydrin followedby dehydrobromination, and characterized by u.v. – vis,and 1H n.m.r. spectroscopy and mass spectrometry. The mutagenicityof these compounds was investigated in the Ames plate incorporationassay with Salmonella typhimurium strain TA98. All the oxideswere active without exogenous metabolic activation (170–320His+ revertants per nanomole) and also toxic above 0.5 µg/plate.Addition of S9 protein did not increase, and generally decreased,the mutagenicity of the oxides, while toxicity was largely unchanged.These results are consistent with the postulated role of cyclopentaoxides as major contributors to the mutagenicity of the parentcompounds in the Ames assay.  相似文献   
8.
9.
10.
ABSTRACT The paper explores two literary texts - Dostoevsky's novel Crime and Punishment and Euripides'play Bacchae - from the point of view of immature masculinity and the catastrophe that can follow if the boy fails to achieve a genuine separation from the maternal object. The author examines the masculine anxieties and defences that arise when the boy fails to work through the Oedipus complex and instead retreats to a dyadic relation with mother which excludes the father. This retreat involves a denial of reality and the creation of a paranoid world in which his own wishes to take possession of mother can be experienced by him as an intrusion by the mother into his own masculine identity and ultimately as castration by the mother. Attempts to resolve this threat to masculinity include the use of anal defences and tyrannical states of mind in the creation of a pseudo-masculinity.
The movement into the male Oedipus complex necessarily involves a psychological state in which the externality of the oedipal-object mother is continually in danger of being blurred by the shadow cast by the pre-oedipal mother. (Thomas Ogden 1992)  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号